Tempest Therapeutics, Inc. (TPST) Insider Trading

Name: Tempest Therapeutics, Inc. (TPST) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 2, 2026): Smith Nancy Freda (Director): Grant/Award of 25,000 shares.

Get alerted when insiders trade TPST

Email address

Loading company data...

Loading company details...